Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
BNT162b2 Approved by FDA Experimental Vaccine Jun/22/2022 65 0
mRNA-1273 Emergency use authorization Experimental Vaccine Jun/22/2022 27 1
ChAdOx1 nCoV-19 Emergency use authorization Experimental Vaccine Jan/04/2022 16 1
4-[2-(2-Benzyloxycarbonylamino-3-t-butoxy-butyrylamino)-4-methyl-pentanoylamino]-5-(2-oxo-pyrrolidin-3-yl)-pent-2-enoic acid ethyl ester Potential treatment - pre-clinical evidence Experimental Antiviral Apr/28/2021 2 0
GC376 Potential treatment - pre-clinical evidence Experimental Antiviral Apr/28/2021 12 0
Qing Fei Pai Du Tang Potential treatment - clinical evidence Natural product Antiviral Feb/28/2021 2 0
Excel (.xslx) CSV (.csv)